Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of COPD Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of COPD Drugsmarket, defines the market attractiveness level of COPD Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of COPD Drugs industry, describes the types of COPD Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global COPD Drugs market and the development prospects and opportunities of COPD Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global COPD Drugs market in Chapter 13.
By Player:
GlaxoSmithKline
Roche Holding AG
Boehringer Ingelheim
Merck & Co
Teva Pharmaceutical
Sumitomo Dainippon Pharma
AstraZeneca
Pfizer
Grifols
By Type:
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 COPD Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 COPD Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 COPD Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 COPD Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise COPD Drugs Market Analysis and Outlook to 2022
-
7.1 Global COPD Drugs Consumption (2017-2022)
-
7.2 United States COPD Drugs Consumption (2017-2022)
-
7.3 Europe COPD Drugs Consumption (2017-2022)
-
7.4 China COPD Drugs Consumption (2017-2022)
-
7.5 Japan COPD Drugs Consumption (2017-2022)
-
7.6 India COPD Drugs Consumption (2017-2022)
-
7.7 South Korea COPD Drugs Consumption (2017-2022)
8 Region and Country-wise COPD Drugs Market Analysis and Outlook to 2028
-
8.1 Global COPD Drugs Consumption Forecast (2022-2028)
-
8.2 United States COPD Drugs Consumption Forecast (2022-2028)
-
8.3 Europe COPD Drugs Consumption Forecast (2022-2028)
-
8.4 China COPD Drugs Consumption Forecast (2022-2028)
-
8.5 Japan COPD Drugs Consumption Forecast (2022-2028)
-
8.6 India COPD Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea COPD Drugs Consumption Forecast (2022-2028)
9 Global COPD Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global COPD Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
9.1.2 Global PDE-4 Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Steroids Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Combination Therapies Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global COPD Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global COPD Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global COPD Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global PDE-4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Combination Therapies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global COPD Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global COPD Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global COPD Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global COPD Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 COPD Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global COPD Drugs Market Competitive Analysis
-
14.1 GlaxoSmithKline
-
14.1.1 GlaxoSmithKline Company Details
-
14.1.2 GlaxoSmithKline COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 GlaxoSmithKline COPD Drugs Product and Service
-
14.2 Roche Holding AG
-
14.2.1 Roche Holding AG Company Details
-
14.2.2 Roche Holding AG COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Holding AG COPD Drugs Product and Service
-
14.3 Boehringer Ingelheim
-
14.3.1 Boehringer Ingelheim Company Details
-
14.3.2 Boehringer Ingelheim COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Boehringer Ingelheim COPD Drugs Product and Service
-
14.4 Merck & Co
-
14.4.1 Merck & Co Company Details
-
14.4.2 Merck & Co COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Merck & Co COPD Drugs Product and Service
-
14.5 Teva Pharmaceutical
-
14.5.1 Teva Pharmaceutical Company Details
-
14.5.2 Teva Pharmaceutical COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Teva Pharmaceutical COPD Drugs Product and Service
-
14.6 Sumitomo Dainippon Pharma
-
14.6.1 Sumitomo Dainippon Pharma Company Details
-
14.6.2 Sumitomo Dainippon Pharma COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sumitomo Dainippon Pharma COPD Drugs Product and Service
-
14.7 AstraZeneca
-
14.7.1 AstraZeneca Company Details
-
14.7.2 AstraZeneca COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca COPD Drugs Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer COPD Drugs Product and Service
-
14.9 Grifols
-
14.9.1 Grifols Company Details
-
14.9.2 Grifols COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Grifols COPD Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of COPD Drugs
-
Figure COPD Drugs Picture
-
Table Global COPD Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global COPD Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global COPD Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global COPD Drugs Consumption by Country (2017-2022)
-
Figure United States COPD Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe COPD Drugs Consumption and Growth Rate (2017-2022)
-
Figure China COPD Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan COPD Drugs Consumption and Growth Rate (2017-2022)
-
Figure India COPD Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea COPD Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global COPD Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States COPD Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe COPD Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China COPD Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan COPD Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India COPD Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea COPD Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bronchodilators Consumption and Growth Rate (2017-2022)
-
Figure Global PDE-4 Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Steroids Consumption and Growth Rate (2017-2022)
-
Figure Global Combination Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Bronchodilators Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global PDE-4 Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Steroids Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Combination Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global COPD Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global COPD Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline COPD Drugs Product and Service
-
Table Roche Holding AG (Foundation Year, Company Profile and etc.)
-
Table Roche Holding AG COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Holding AG COPD Drugs Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim COPD Drugs Product and Service
-
Table Merck & Co (Foundation Year, Company Profile and etc.)
-
Table Merck & Co COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co COPD Drugs Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical COPD Drugs Product and Service
-
Table Sumitomo Dainippon Pharma (Foundation Year, Company Profile and etc.)
-
Table Sumitomo Dainippon Pharma COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sumitomo Dainippon Pharma COPD Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca COPD Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer COPD Drugs Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols COPD Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols COPD Drugs Product and Service
-
